lunes, 30 de marzo de 2026

TRENDING WITH ALLERGISTS +++ +++ +

TRENDING WITH ALLERGISTS Early Risk Factors for Food Allergy Uncovered Early Skin and Respiratory Allergies Predict Food Allergy, Study Finds Lara Salahi https://www.medscape.com/viewarticle/early-skin-and-respiratory-allergies-predict-food-allergy-2026a10007ae?ecd=mkm_ret_260330_mscpmrk_allergy_top-content_etid8218795&uac=148436CN&impID=8218795 March 10, 2026 GLP-1 Adverse Effects: Practical Tips for Clinicians GLP-1 Adverse Effects: Practical Tips for Clinicians Kevin Fernando, MBChB https://www.medscape.com/viewarticle/1003255?ecd=mkm_ret_260330_mscpmrk_allergy_top-content_etid8218795&uac=148436CN&impID=8218795 March 18, 2026 Allergy Affects 1 in 4 With Immunodeficiency Allergy Affects 1 in 4 With Common Variable Immunodeficiency Edited by Archita Rai https://www.medscape.com/viewarticle/allergy-affects-1-4-common-variable-immunodeficiency-2026a100090y?ecd=mkm_ret_260330_mscpmrk_allergy_top-content_etid8218795&uac=148436CN&impID=8218795 March 25, 2026 Panel Endorses Early Introduction of These Food Allergens Expert Panel Endorses Early Introduction of Potential Food Allergens Heidi Splete https://www.medscape.com/viewarticle/expert-panel-endorses-early-introduction-potential-food-2026a100084j?ecd=mkm_ret_260330_mscpmrk_allergy_top-content_etid8218795&uac=148436CN&impID=8218795 March 17, 2026 Drug Approved for Allergic Fungal Rhinosinusitis Dupilumab Approved for Allergic Fungal Rhinosinusitis Mia Sims https://www.medscape.com/viewarticle/dupilumab-approved-allergic-fungal-rhinosinusitis-2026a10005zi?ecd=mkm_ret_260330_mscpmrk_allergy_top-content_etid8218795&uac=148436CN&impID=8218795 February 25, 2026 JAK Inhibitor Safe for Kids’ Atopic Dermatitis: New Data Data Support Ruxolitinib’s Safety for Kids’ Atopic Dermatitis Heidi Splete https://www.medscape.com/viewarticle/data-support-ruxolitinibs-safety-kids-atopic-dermatitis-2026a10008i4?ecd=mkm_ret_260330_mscpmrk_allergy_top-content_etid8218795&uac=148436CN&impID=8218795 March 20, 2026 SLIT Appears Safe and Effective for Dust Mite Allergy Sublingual Immunotherapy Appears Safe and Effective for House Dust Mite-Induced Allergic Rhinoconjunctivitis Edited by Mandeep Singh Rawat https://www.medscape.com/viewarticle/sublingual-immunotherapy-appears-safe-and-effective-house-2026a10007m7?ecd=mkm_ret_260330_mscpmrk_allergy_top-content_etid8218795&uac=148436CN&impID=8218795 March 12, 2026

No hay comentarios:

Publicar un comentario